Views & Analysis Pharma improves HCP engagement during COVID-19 – report Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs.
Views & Analysis What HCPs think about pharma For a long time, I have been observing how healthcare professionals (HCPs) are talking about the pharmaceutical industry – including their conversations about how the pharmaceutical industr
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.